NKL 22, 98%, a HDAC inhibitor

Name: NKL 22, 98%, a HDAC inhibitor | 537034-15-4
Brand: J&K Chemical
SKU: JK836786_5_MG
Price: 57.0 USD
Availability: OutOfStock

Cat. No JK836786_5_MG

Vendor: J&K Chemical

Product Information

Product Name

NKL 22, 98%, a HDAC inhibitor

Brand Name

J&K

Product Number

836786

CAS

537034-15-4

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

9543539

IUPAC Name

N'-(2-aminophenyl)-N-phenylheptanediamide

InChI Key

ZAIULUYKQLVQFH-UHFFFAOYSA-N

SMILES

C1=CC=C(C=C1)NC(=O)CCCCCC(=O)NC2=CC=CC=C2N

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2019-03-15

DOI: 10.1016/j.ejmech.2019.01.077

Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)

Publication Name: Journal of Medicinal Chemistry

Publication Date: 2017-08-03

DOI: 10.1021/acs.jmedchem.7b00115

Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells

Publication Name: Retrovirology

Publication Date: 2017-02-06

DOI: 10.1186/s12977-017-0335-8

Novel uracil-based 2-aminoanilide and 2-aminoanilide-like derivatives: Histone deacetylase inhibition and in-cell activities

Publication Name: Bioorganic & Medicinal Chemistry Letters

Publication Date: 2008-04-15

DOI: 10.1016/j.bmcl.2008.03.055

Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia

Publication Name: Nature Chemical Biology

Publication Date: 2006-08-20

DOI: 10.1038/nchembio815

NKL 22, 98%, a HDAC inhibitor

Product Information

General Information

Safety Information

References Data Source From Pubchem

Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides

Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)

Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells

Novel uracil-based 2-aminoanilide and 2-aminoanilide-like derivatives: Histone deacetylase inhibition and in-cell activities

Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia